CURRICULUM VITAE

801 views
711 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
801
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

CURRICULUM VITAE

  1. 1. CURRICULUM VITAE BARRY DAVID SILVERMAN, M.D. OFFICE ADDRESS: Northside Cardiology 960 Johnson Ferry Road Suite 500 Atlanta, GA 30342 (404) 256-2525 JOB POSITION: Cardiologist, practice established 1973 MEDICAL SCHOOL: Ohio State University Degree BS/MD 1960-1967 INTERNSHIP & Vanderbilt University Hospital RESIDENCY: Department of Medicine ` July 1, 1967 to July 1, 1969 FELLOWSHIP: Johns Hopkins University Hospital Department of Cardiology July 1, 1971- July 1, 1973 TEACHING APPOINTMENTS: Emory University Department of Medicine (Cardiology) 1973 to present MEMBERSHIP ON Vanderbilt University Hospital HOSPITAL STAFFS Nashville, TN Johns Hopkins University Hospital, Baltimore, MD Grady Memorial Hospital, Atlanta, GA Northside Hospital, Atlanta, GA St. Joseph Hospital, Atlanta, GA MEMBERSHIPS: American College of Physicians American Heart Association American Medical Association American College of Cardiology
  2. 2. Atlanta Medical History Society American Osler Society POSITIONS: Director of Cardiology Northside Hospital 1973-2001 Director of Internal Medicine Education 1973-2001 Chairman of Northside Hospital IRB 1999-2001 Editor Medical Association of Atlanta Journal Atlanta Medicine 2000- Chairman education committee “Georgia Chapter American College of Physicians Chairman education committee Georgia Chapter American College of Cardiology in charge of the Annual scientific meeting 2000-2004 FELLOWSHIP: American College of Physicians American College of Cardiology CERTIFIED: American Board of Internal Medicine Medicine 1972; Cardiology 1974 MILITARY SERVICE: U.S. Public Health Service July 1969- July 1971 PUBLICATIONS: Graybill, RJ, Silverman, BD “Sulfur Granules (Second Thoughts)” Arch Internal Med 123:430 -432 1969 Silverman, BD “Treading the Mill” Atl. Med. 29: 15-16 1975 Silverman, BD, Matthews, O. “Hemodynamic Monitoring with the Swan-Ganz Catheter” Atl Med 49:12 1975 Silverman, BD, Kozma, G. Silverman, ME, King, S “Echocardiographic Manifestations of Post- Infarction Ventricular Septal Rupture”Chest 68: 778-780 1975 PUBLICATIONS: Silverman, BD, “Valvular Heart Disease”
  3. 3. Chapter in Fourth Edition of the The Heart Editied by J. Willis Hurst,M.D. Published By McGraw Hill Publishing Co. 1974 Silverman, BD, Silverman, ME, “The Diagnostic Capabilities and Limitations Of the Electrocardiogram” Update I The Heart Edited by J. Willis Hurst, M.D. Published by McGraw Hill Publishing Co. Pp 13-45 1979 Silverman, BD, “Unstable Angina Pectoris” Hospital Medicine May 1982 pp 32 Silverman, BD, Carabajal, ND, Chorches, MA “Tricuspid Regurgitation and Acute Myocardial Infarction” Arch Int Med 7:1394-5 1982 Silverman, BD, Berry, JN, Flowers, C “The Symptom Complex of Mitral Valve Prolapse And Its Association with the DaCosta Syndrome SMA 77,I:27-29 1984 DiBianco, R, Shabitar, R, Silverman, BD, Leior, C “Oral Amrinone for the Treatment of Chronic Congestive Heart Failure: Results of Multicenter Randomized Double-blinded and Placebo controlled Withdrawl Study J Am Coll Cardiol 1984 4(5):855-66 Silverman, BD Neeld, J “Evaluation of the Cardiac Patient for Non-Cardiac Surgery J Med Ass GA 73:315-318 1984 Davis, SG, Silverman, BD “ Hemodynamic Monitoring” Cardiovascular Nursing BodyMind Tapestry C.V. Mosby Unit III Chapter 10: 253- 274 Silverman, BD, Merrill, A Gerber, L “Amrinone Clinical Effects and Side Effects of Amrinone, Arch Int Med 1985 145(5):825-9 CAST Investigators “Preliminary Report: Effect
  4. 4. Encaninide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction NEJM 1989 321: 406-412 Silverman, BD Carl J Wiggers-the Inventive Physiologist 1883-1963 Clinical Cardiology 1989 12:731-734 Silverman, BD Reflex Syncope Current Understanding of the Pathophysiology and Therapies J Med Ass GA 1991 80: 39-43 Bradford, RH, Shear, CL Chremos, AN and Excel Study investigators Expanded Clinical Evaluation of Lovastatin (Excel Study Results) Arch Int Med 1991 151:43-49 Collentine T, Collier, MJ, Crews, T, Davis, W Morris, D, Silverman, BD, Wilmer, C, Wilson Jr, JS, A Stitch in Time for the Heart Attack Patient J Med Ass GA 1995 84:22-26 Silverman, BD Jean Baptiste Bouillaud Clinical Cardiology 1996 19(10):836-7 Silverman, BD Mitral Valve Prolapse: Clinical Assessment and Management Strategies Resident and Staff Physician January 1998 Cohn, JN and Vernarinone Investigators A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure NEJM 1998 339:1810-16 MERIT INVESTIGATORS STUDIES Wikstrand, J, Hialmarson, A, Waagstein, F, Goldstein, S and Merit Investigators Dose Of metoprolol CR/XL and clinical outcomes in Patients with heart failure: analysis of the Experience in metoprolol CR/XL randomized Intervention trial in Chronic heart failure J Am Coll Cardiol 2002 40:(3)491-8
  5. 5. Wikstrand J, Hjalmarson A, Waagstein F, Fagerberg B, Goldstein S, KjekshusJ, Wedel H. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure:analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).J Am Coll Cardiol. 2002 Aug 7;40(3):491-8. Goldstein S, Fagerberg B, Hjalmarson A, Waagstein F, Wedel H, Wikstrand J. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study.J Am Coll Cardiol. 2001 Oct;38(4):932-8. Ghali JK, Pina IL, Gottlieb SS, Deedwania PC, Wikstrand JC. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in HeartFailure (MERIT-HF). Circulation. 2002 Apr 2;105(13):1585-91. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)Lancet.1999 Jun 12;353(9169):2001-7. Goldstein S, Hjalmarson A. The mortality effect of metoprolol CR/XL in patients with heart failure: resultsof the MERIT-HF Trial. Clin Cardiol. 1999 Oct;22 Suppl 5:V30-5. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J,Wikstrand J, El Allaf D, And MERIT Investigators Effects of controlled-release metoprolol on total mortality, hospitalizations,and well-being in patients with heart failure: the Metoprolol CR/X Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000 Mar 8;283(10):1295-302. Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J Wikstrand J.
  6. 6. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation. 2002 Mar 12;105(10):1182-8. Silverman, BD Safety and Benefits of transferring patients with Acute MI to interventional Center for Immediate PCI J Am Coll Card letter to editor 2003 41(3):518

×